54Z-25690-06420
3 vaccinations
2 coded responses
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 432 / OH
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Moderna
-
2021-01-06
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-20
-
2021-01-27
Survey response — day 21, dose 1MedDRA: Fatigue, Insomnia, Nasal congestion, Oropharyngeal pain, Rhinorrhoea, Throat irritation — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Stuffy, runny nose, sore throat, scratchy throat, fatigue, insomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-02-03
-
2021-02-08
Dose 2 — Moderna
-
2021-02-17
Health check-in — day 7, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-05-10
- 2021-08-09
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2022-02-08
-
2022-11-05
Survey response — 12 months, dose 3MedDRA: Pyrexia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: FeverMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna | |
| 2 | 2021-02-08 | Moderna | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-27 | priority 2/3 |
Free text
Release 2 — day 21, dose 1
Symptoms: Stuffy, runny nose, sore throat, scratchy throat, fatigue, insomnia
Release 12 — 12 months, dose 3
Symptoms: Fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Throat irritation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release